ViralVacDB | Details of Viral Vaccine

Details of Viral Vaccine

This Viral vaccine card gives comprehensive information about each vaccine.
Detailed Information
ID10251
Vaccine NamehAd5-COVID-19
Disease NameCOVID-19
Disease ClassificationRespiratory
Virus NameSARS-CoV-2 virus
Nucleic Acid Contentpositive-sense, single-stranded RNA
Vaccine TypeRecombinant viral vector
Vaccine StatusPhase 2
ManufacturerImmunityBio Inc.
Year of Manufacturing2021
Manufacturing CountryUSA
Age18 - 80 years
DosageNA
Administration RouteSubcutaneous
AdjuvantNA
Target StrainSpike & Nucleocapsid protein
DescriptionNA
Approving OrganisationNA
Collaborating OrganisationNA
Other CountriesNA
Trade NameNA
PMID33937326
Clinical Trial IDNCT04843722
Reference Linkhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082173/
Additional LinksNA